PET developing agent precursor TsOP-(+)-DTBZ and separation and measurement method of optical isomer thereof

A PET imaging agent and measurement method technology, applied in the field of analytical chemistry, to achieve the effect of good peak symmetry

Active Publication Date: 2016-10-12
JIANGSU INST OF NUCLEAR MEDICINE
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Therefore, the technical problem to be solved by the present invention is to overcome the defect that there is no separation and detection method for the labeling precursor TsOP-(+)-DTBZ and its optical isomers in the prior art, thereby providing a PET imaging agent precursor TsOP- The separation and determination method of (+)-DTBZ and its optical isomers, and then realize the separation and determination of the precursor and its optical isomers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PET developing agent precursor TsOP-(+)-DTBZ and separation and measurement method of optical isomer thereof
  • PET developing agent precursor TsOP-(+)-DTBZ and separation and measurement method of optical isomer thereof
  • PET developing agent precursor TsOP-(+)-DTBZ and separation and measurement method of optical isomer thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Instruments and Conditions

[0046] Mobile phase: n-hexane-1,2-dichloroethane-absolute ethanol-trifluoroacetic acid-triethylamine=65:33:2:0.01:0.005

[0047] Flow rate: 0.8mL / min

[0048] Column temperature: 25°C

[0049] Injection volume: 20μL

[0050] UV detection wavelength 280nm

[0051] Experimental steps:

[0052] Accurately weigh 5 mg of TsOP-(+)-DTBZ and its isomers respectively, put them in a 10 mL brown volumetric flask, add mobile phase to dissolve and dilute to the mark, shake well, and use it as the test solution. Get need testing solution and carry out high performance liquid chromatography analysis according to above-mentioned conditions, record chromatogram.

[0053] see attached results figure 1 , it can be seen that TsOP-(+)-DTBZ and its isomers achieve baseline separation under this condition, and the high performance liquid chromatography shows a resolution of 2.5.

Embodiment 2

[0055] Instruments and Conditions

[0056] Mobile phase: n-hexane-1,2-dichloroethane-absolute ethanol-trifluoroacetic acid-triethylamine=64.6:32.3:3.1:0.01:0.005

[0057] Flow rate: 0.8mL / min

[0058] Column temperature: 30°C

[0059] Injection volume: 20μL

[0060] UV detection wavelength 280nm

[0061] Experimental steps:

[0062] Accurately weigh 10 mg of TsOP-(+)-DTBZ and its isomers respectively, put them in a 10 mL brown volumetric flask, add mobile phase to dissolve and dilute to the mark, shake well, and use it as the test solution. Get need testing solution and carry out high performance liquid chromatography analysis according to above-mentioned conditions, record chromatogram.

[0063] see attached results figure 2 , showing that the separation and detection method of the present invention can separate TsOP-(+)-DTBZ and its isomers, and the high-performance liquid chromatography shows that the separation degree is 2.2.

Embodiment 3

[0065] Instruments and Conditions

[0066] Mobile phase: n-hexane-1,2-dichloroethane-absolute ethanol-trifluoroacetic acid-triethylamine=64:32:4:0.01:0.005

[0067] Flow rate: 0.8mL / min

[0068] Column temperature: 25°C

[0069] Injection volume: 20μL

[0070] UV detection wavelength 280nm

[0071] Experimental steps:

[0072] Accurately weigh 5 mg of TsOP-(+)-DTBZ and its isomers respectively, put them in a 10 mL brown volumetric flask, add mobile phase to dissolve and dilute to the mark, shake well, and use it as the test solution 1. In addition, accurately weigh 10 mg of TsOP-(+)-DTBZ bulk drug, put it in a 10 mL brown volumetric flask, add mobile phase to dissolve and dilute to the mark, shake well, and use it as the test solution 2.

[0073] Get need testing solution and carry out high performance liquid chromatography analysis by above-mentioned conditions, record chromatogram, the result sees attached image 3 .

[0074] image 3 It is proved that this method ca...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
wavelengthaaaaaaaaaa
separationaaaaaaaaaa
Login to view more

Abstract

The invention discloses a PET developing agent precursor TsOP-(+)-DTBZ and a separation and measurement method of an optical isomer thereof and belongs to the field of analytical chemistry. The separation and measurement method is a normal-phase chromatography by means of a Pirkle type chiral stationary phase chromatographic column and with a normal-phase mixed solvent serving as a mobile phase for separation. By means of the method, the PET developing agent precursor and the optical isomer of the PET developing agent precursor can be easily, quickly and accurately separated and detected, and the mass of the precursor TsOP-(+)-DTBZ can be effectively controlled.

Description

technical field [0001] The invention relates to the field of analytical chemistry, in particular to a method for separating and measuring PET imaging agent precursor TsOP-(+)-DTBZ and its optical isomers. Background technique [0002] Parkinson's disease (PD) is a common degenerative disease of the central nervous system, which is more common in the elderly. Work and life, because people are not familiar with the early symptoms, the best time for treatment has been missed by the time of diagnosis, so early diagnosis and early treatment are extremely important. The pathogenesis of PD is still unclear, and the degeneration of dopaminergic neurons in the nigrostriatum is the main pathological feature of PD. Studies suggest that the reduction of central vesicular monoamine transporter (VMAT2) caused by genetic or environmental factors is an important determinant of PD pathogenesis. Therefore, using molecular imaging techniques, positron emission tomography (PET) and The develo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/02G01N30/60
CPCG01N30/02G01N30/60G01N2030/027
Inventor 李晓敏陈正平刘春仪唐婕薛丹露曹丽华徐栋
Owner JIANGSU INST OF NUCLEAR MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap